毛细管电泳法分离四环素及其杂质

用毛细管电泳方法分离四环素和它的主要杂质４－差向四环素，脱水四环素，４－差向脱水四环素和２－乙酰基－２－脱酰胺四环素，相对次要的杂质氯四环素和脱甲四环素也能被分 离。     

毛细管电泳对微生物代谢中硫酸根和硫代硫酸根的分离与测定

建立了微生物代谢中硫酸根和硫代硫酸根的毛细管电泳分析方法．在选定实验条件下，各种阴离子（Ｓ２Ｏ２－３、ＳＯ２－４、ＣＩ－、ＮＯ－３、ＰＯ３－４）在４ ｍｉｎ内达到完全分离，其中 Ｓ２Ｏ２－３和ＳＯ２－４迁移时间的相对标准偏差小于１％，峰面积的相对标准偏差小于５％．测定了４种菌株分别在两种培养基中的Ｓ２Ｏ２－３和ＳＯ２－４浓度随培养时间的变化．结果表明，其中一菌株在ＳＫ基中对Ｓ２Ｏ２－３有明显的氧化作用．     

毛细管离子交换电色谱的分离行为

在离子交换毛细管色谱柱上实施电色谱，并对其分离行为进行了研究，采用７５μｍ（ｉ．ｄ．）２０ｃｍ的毛细管强阳离子交换柱（３μｍ）以ＮａＨ２ＰＯ４－Ｈ３ＰＯ４缓冲液为淋洗剂，紫外柱上检测（２１４ｎｍ）考察了流动相的ｐＨ值，有机改性剂及分离电压等因素对分离的影响，研究表明，不同的ｐＨ溶质的流出次序发生改变，随着有机改性剂含量增加，溶质的保留时间减小，而电渗流却增大，同时，对分离的柱效和方法的重现性进行了     

萃取色谱分离—原子发射光谱测定氧化钐,氧化铕,氧化钆中14个稀土杂质

用２－乙基己基膦酸单２－乙基己酯萃取色谱分离－原子发射光谱测定超高纯Ｓｍ２Ｏ３、Ｅｕ２Ｏ３、Ｇｄ２Ｏ３中痕量稀土杂质，可用于纯度为９９９９９９％～９９９９９９９％（不含非稀土杂质）Ｓｍ２Ｏ３、Ｅｕ２Ｏ３、Ｇｄ２Ｏ３的纯度分析，１４个稀土杂质的回收率在６７％～１３３％之间，相对标准偏差±６４％～±１８４％，分离周期１０～１４ｈ。     

采用毛细管电泳电堆集富集技术分离与测定雪样中的痕量阳离子

以咪唑为背景电解质,以α－羟基异丁酸和１８－冠醚－６为络合剂,采用毛细管离子电泳间接紫外法,研究了发样中痕量ＮＨ４＾＋、Ｋ＾＋、Ｃａ＾＋、Ｍｇ＾２＋分离与测定的方法。通过向缓冲液中加入甲醇,使Ｃａ＾２＋、Ｎａ＾＋迁移顺序发生反转,有利于在Ｃａ＾２＋的浓度较高时少量Ｎａ＾＋的测定。采用电堆集富集技术,各离子的检测限达１×１０＾－７ｍｏｌ／Ｌ。以Ｌｉ＾＋作为内标,采用标准加入法对地样中的痕量阳离子进行     

离子对反相色谱法研究（E）－4，4′－二氨基二苯乙烯－2，2′－二磺酸及其杂质组分

建立了离子对反相ＨＰＬＣ分离测定（Ｅ）－４，４′－二氨基二苯乙烯－２，２′二磺酸［（Ｅ）ＤＡＳ］及其中间产物和杂质组分的方法。解决了测定的稳定性问题，且各组分线性范围宽，检测限低。已用于工业样品的测定，结果令人满意。     

正相高效液相色谱法分离和测定2—（4—羟基苯氧基）丙酸

采用在硅胶柱（ＺＯＲＢＡＸ ＳＩＬ）上，以正己烷：乙酸＝７０：３０：２．５为流动相及ＵＶ检测器（２５４ｎｍ）的高效液相色谱法分离和测定２－（４－羟基苯氧基）丙酸。在选定的色谱操作条例上，２－（４－羟基苯氧基）丙酸与杂质对苯二酚等之间具有良好的分离效果。该方法具有较好的重现性和准确性。     

电解还原法生产的对氨基苯酚纯度及杂质的高效液相色谱分析

研究了用高效液相色谱法对电化学生产的对氨基苯酚及杂质４，４＇－二氨基二苯醚和联苯胺含量的测定。方法简单、重现性好，适合工业生产中的快速控制分析，对氨基苯酚产品的相对标准偏差小于１．５％，４，４＇－二氨基二苯醚和联苯胺的相对标准偏差分别小于２．５％和３．０％。     

流动注射与毛细管电泳联用在中药厚朴分析中的应用研究

对流动注射与毛细管电泳联用（ＦＩ－ＨＰＣＥ）技术在中药厚朴分析中的应用进行了研究。采用了一种新的联用接口，并运用单纯形法优化了缓冲液浓度、ｐＨ值及电压、甲醇含量以取得最佳分离效果，使中药厚朴中的有效成分厚朴酚及和厚朴酚与其他杂质得以基线分离。采用优化的条件对中药厚朴及其部分成药进行了分离分析。采样频率１０个样／ｈ，精密度为２．１％，回收率为９６％￣１０２．９％。     

离子对反相色谱法研究（E）－4，4′－二氨基二苯乙烯－2，2′－二磺酸及其杂质组分

 建立了离子对反相ＨＰＬＣ分离测定（Ｅ）－４，４′－二氨基二苯乙烯－２，２′二磺酸［（Ｅ）ＤＡＳ］及其中间产物和杂质组分的方法。解决了测定的稳定性问题，且各组分线性范围宽，检测限低。已用于工业样品的测定，结果令人满意。     

Separation of tetracycline and its related substances by capillary zone electrophoresis

Tetracycline was separated from its main impurities 4-epitetracycline, anhydrotetracycline, 4-epianhydrotetracycline, chlortetracycline, and demethyltetracycline by capillary electrophoresis. Systematic method development was performed in which following parameters were consecutively optimized: type and pH of the buffer, buffer concentration, type and concentration of organic modifier, voltage and temperature. Qualitative and quantitative aspects of the method are compared with liquid chromatography.     

Analysis of process impurities in the basic drug SB-253149 using capillary electrophoresis and on-line mass spectrometric detection

Capillary electrophoresis with on-line electrospray ionisation mass spectrometry (CE/ESI-MS) has been used to identify process impurities in a batch of the anti-atherosclerotic drug, SB-253149. The impurities were separated from the main drug compound by capillary electrophoresis (CE) using an ammonium formate buffer at low pH in an untreated fused silica capillary. The CE method was initially developed using UV as the detection mode and then later structural elucidation work was achieved using an ion trap mass spectrometer. To maintain peak resolution and peak shape when the CE system was coupled to the mass spectrometer, a modified capillary cassette linked to a coaxial sheath flow electrospray ionisation (ESI) interface was used. By performing MS/MS experiments in conjunction with chemical knowledge of the reactivities of SB-253149, it was possible to propose molecular structures for impurities detected in the batch of SB-253149. The results from this study revealed that most of the process impurities in SB-253149 were dimeric derivatives of the parent molecule as well as trace levels of the starting material. This type of information was vital in process control and optimisation for the synthetic route for this drug.     

Capillary zone electrophoresis method for the determination of famotidine and related impurities in pharmaceuticals

A simple and rapid capillary zone electrophoresis (CZE) method with UV detection has been developed for the determination of famotidine and its potential impurities in pharmaceutical formulations. The electrophoretic separation of these compounds was performed using a fused silica capillary and 37.5mmolL(-1) phosphate buffer pH 3.5 as the electrolyte. Under the optimised conditions, six impurities could be resolved from the famotidine peak in less than 7min. The calibration curves obtained for the seven compounds were linear over the concentration range investigated (from 1.5 to 78.5microg mL(-1)). The intra- and inter-day relative standard deviations for the migration times and corrected peak areas were less than 2% and 5%, respectively. The detection limits were found to be 0.09microg mL(-1) for famotidine, and from 0.1 to 0.62microg mL(-1) depending on the impurities. The method has been successfully applied to the determination of famotidine in commercial dosage forms.     

Purity control of oxytetracycline by capillary electrophoresis

The applicability of capillary electrophoresis for the purity control of oxytetracycline (OTC) was investigated. OTC is a broad-spectrum antibiotic belonging to the group of the tetracyclines. Several related substances can be present due to fermentation or degradation, such as 4-epioxytetracycline, -apooxytetracycline, β-apooxytetracycline, anhydrooxytet racycline, 2-acetyl-2-decarboxamidooxytetracycline, tetracycline and 4-epitetracycline. Using fused-silica capillaries, the influence of buffer type, buffer pH and buffer concentration were investigated. In all cases 1 mM EDTA was added to prevent metal-ion complexation. The influence of the buffer counter-ion type was examined. Consequently, some instrumental parameters were changed such as capillary length and diameter as well as capillary temperature and applied voltage. The following method is finally proposed: fused-silica capillary, l (effective length) = 38 cm, L (total length) = 44 cm, 50 μm I.D.; buffer, sodium carbonate 20 mM-EDTA 1 mM, pH 11.25; voltage, 10 kV; temperature, 10°C. Linearity, limit of detection and limit of quantitation were determined as well as the relative standard deviations for all the analytes involved. This method is less selective then existing liquid chromatographic methods but it may be used as a complementary tool in purity control and stability studies.     

Approach to method development and validation in capillary electrophoresis for enantiomeric purity testing of active basic pharmaceutical ingredients

A chiral capillary electrophoresis system allowing the determination of the enantiomeric purity of an investigational new drug was developed using a generic method development approach for basic analytes. The method was optimized in terms of type and concentration of both cyclodextrin (CD) and electrolyte, buffer pH, temperature, voltage, and rinsing procedure. Optimal chiral separation of the analyte was obtained using an electrolyte with 2.5% carboxymethyl-beta-CD in 25 mM NaH2PO4 (pH 4.0). Interchanging the inlet and outlet vials after each run improved the method's precision. To assure the method's suitability for the control of enantiomeric impurities in pharmaceutical quality control, its specificity, linearity, precision, accuracy, and robustness were validated according to the requirements of the International Conference on Harmonization. The usefulness of our generic method development approach for the validation of robustness was demonstrated.     

Enantioseparation of warfarin and its metabolites by capillary zone electrophoresis

A capillary zone electrophoresis (CZE) method with direct ultraviolet (UV)-absorbance detection is presented for the simultaneous enantiomeric separation of warfarin and its main metabolites, including warfarin alcohols, 4'-, 6-, and 7-hydroxywarfarin, using highly sulfated beta-cyclodextrin (HS-beta-CD) as the chiral selector. This chiral separation method was optimized in terms of the electrophoretic parameters, which included the concentration of HS-beta-CD used, the type and composition of organic modifier added to the background electrolyte (BGE) buffer, and the BGE buffer pH. Chiral separation of warfarin and its major metabolites was achieved with high resolution, selectivity, efficiency, repeatability, and reproducibility. This optimized chiral analysis of warfarin along with its metabolites was completed within a satisfactory electrophoresis time of 20 min.     

Non-aqueous capillary electrophoresis with diode array and electrospray mass spectrometric detection for the analysis of selected steroidal alkaloids in plant extracts

A capillary electrophoresis (CE) assay has been developed for the quantitation and determination of the impurity profile of the potassium channel blockers 3,4-diaminopyridine and 4-aminopyridine. The compounds were separated from related substances using a capillary of 30 cm effective length, a 50 mM phosphate buffer, pH 2.5 and an applied voltage of 25 kV. The assay was validated with respect to specificity, linearity, range, limits of quantitation and detection, precision and robustness. The method allows the detection and quantitation of impurities at the 0.05% level. The feasibility of the assay was demonstrated by analyzing a commercial sample of 3,4-diaminopyridine. All known related substances could be detected in this sample with the present CE method.     

Capillary electrophoresis determination of diatrizoic acid and its impurities in diatrizoate radiopaque solutions

A capillary electrophoresis method has been developed for the separation and determination of diatrizoic acid (DTZA) and its four mono- and diiodo degradation products (2-iodo,4-iodo, 2,4-diiodo, and 2,6-diiodo-3,5-diacetamidobenzoic acid) in radio-paque solution for injection (RSI). DTZA and its degradants were assayed in suitable dilutions without pretreatment. Optimum conditions included the use of low-pressure sample injection (6 s), sample and standard solutions with a molarity less than that of the separation buffer, and adjustment of the buffer molarity to obtain a current of 50 A at a constant 15kV separation voltage. After each six runs or less, the inlet and outlet buffer were replaced with more buffer from the same batch. When the method was applied to a sample of SI levels of 5–10 mg/ml were found for each of the mono and diiodo impurities. The optimum method showed a precision (peak area measurement) in the range 1.7–7.2% RSD, depending on the concentration. A linear correlation coefficient of 0.997 was obtained over a DTZA concentration range of 5–60 mg/mL.     

Determination of oxytetracycline and some impurities in plasma by non-aqueous capillary electrophoresis using solid-phase extraction

Summary The potential of a non-aqueous, capillary electrophoresis (NACE) system for separating oxytetracycline from three of its impurities—tetracycline, 4-epioxytetracycline and 4-epitetracycline—using UV detection has been studied. The running buffer was: 25 mM sodium acetate, 1 mM EDTA, methanesulfonic acid, pH 4, dissolved in MeOH-ACN (50∶50,v/v). The method was also used to determine these compounds in pig plasma. A solid-phase extraction (SPE) procedure as a clean-up step has also developed. For this we tested Sep Pak C₁₈, LiChrolut EN and OASIS cartridges. OASIS cartridges were best. Recoveries were 90–100% for all compounds except EOTC which had a recovery of 74%.